![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Polypeptide Laboratories (sweden) Ab Limhamn Se, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Calcitonin (salmon), Synthetic Origin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 1997-091 - Rev 03
This Chemical Type CEP, issued on February 07, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 471 associated with this CEP further emphasizes